Clinical Practice Guidelines for Sustained Neuromuscular Blockade in the Adult Critically Ill Patient

Critical Care Medicine

Volumn 44, Issue 11, 2016, Pages 2079-2103

  Murray, Michael J ^a   Deblock, Heidi ^b   Erstad, Brian ^c   Gray, Anthony ^d   Jacobi, Judi ^e   Jordan, Che ^f   McGee, William ^g   McManus, Claire ^h   Meade, Maureen ⁱ   Nix, Sean ^j   Patterson, Andrew ^k   Sands, M Karen ^l   Pino, Richard ^m   Tescher, Ann ⁿ   Arbour, Richard ^o   Rochwerg, Bram ^p   Murray, Catherine Friederich ^q   Mehta, Sangeeta ⁱ  

^a GEISINGER MEDICAL CENTER   (United States)

^b ALBANY MEDICAL CENTER   (United States)

^c UNIVERSITY OF ARIZONA   (United States)

^d LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

^e INDIANA UNIVERSITY   (United States)

^f Grand Strand Spine and Neuro Center   (United States)

^g BAYSTATE MEDICAL CENTER   (United States)

^h ST ELIZABETH'S MEDICAL CENTER   (United States)

ⁱ UNIVERSITY OF TORONTO   (Canada)

^j Riverside Medical Group   (United States)

^k UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^l Novant Health   (United States)

^m MASSACHUSETTS GENERAL HOSPITAL   (United States)

ⁿ MAYO CLINIC   (United States)

^o LANCASTER GENERAL HOSPITAL   (United States)

^p MCMASTER UNIVERSITY   (Canada)

^q Medscape LLC   (United States)

more..

Author keywords

acute respiratory distress syndrome; asthma; brain death; end of life; myasthenia gravis; neuromuscular blocking agents; obesity; sedation; therapeutic hypothermia

Indexed keywords

ACETYLCHOLINESTERASE; ARTIFICIAL TEAR; ATRACURIUM BESILATE; CHOLINESTERASE INHIBITOR; CISATRACURIUM; INSULIN; MIVACURIUM; MUSCARINIC RECEPTOR; NEUROMUSCULAR BLOCKING AGENT; NICOTINIC RECEPTOR; PANCURONIUM; PETHIDINE; PYRIDOSTIGMINE; ROCURONIUM; SUXAMETHONIUM; VECURONIUM; ANALGESIC AGENT; HYPNOTIC SEDATIVE AGENT;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ARTIFICIAL VENTILATION; ASTHMATIC STATE; BRADYCARDIA; BRAIN DEATH; BRAIN INJURY; BRONCHOCONSTRICTION; CONTINUOUS INFUSION; CORNEA DISEASE; CORNEAL ABRASION; CRITICALLY ILL PATIENT; DRUG DOSE TITRATION; DRUG MECHANISM; DRUG MONITORING; EYE CARE; EYELID CLOSURE; FLUSHING; GANGLION BLOCK; HEART DISEASE; HISTAMINE RELEASE; HUMAN; HYPOGLYCEMIA; HYPOTENSION; HYPOXEMIA; INDUCED HYPOTHERMIA; INTENSIVE CARE; INTRACRANIAL HYPERTENSION; KERATITIS; MYASTHENIA GRAVIS; NERVE STIMULATION; NEUROMUSCULAR BLOCKING; NEUROMUSCULAR JUNCTION; OBESITY; PHYSIOTHERAPY; PRACTICE GUIDELINE; PREGNANT WOMAN; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; RESPIRATORY ACIDOSIS; REVIEW; SEDATION; SHIVERING; SIDE EFFECT; TACHYCARDIA; TERMINALLY ILL PATIENT; COMPLICATION; CRITICAL ILLNESS; FEMALE; HEMODYNAMICS; NEUROMUSCULAR MONITORING; PHYSIOLOGY; PREGNANCY; RESPIRATORY DISTRESS SYNDROME, ADULT; STATUS ASTHMATICUS; TERMINAL CARE; TREATMENT WITHDRAWAL;

ADULT; ANALGESICS; BRAIN DEATH; CRITICAL ILLNESS; FEMALE; HEMODYNAMICS; HUMANS; HYPNOTICS AND SEDATIVES; HYPOTHERMIA, INDUCED; MYASTHENIA GRAVIS; NEUROMUSCULAR BLOCKADE; NEUROMUSCULAR BLOCKING AGENTS; NEUROMUSCULAR JUNCTION; NEUROMUSCULAR MONITORING; OBESITY; PREGNANCY; RESPIRATORY DISTRESS SYNDROME, ADULT; STATUS ASTHMATICUS; TERMINAL CARE; WITHHOLDING TREATMENT;

EID: 84991717360     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0000000000002027     Document Type: Review

References (230)

1. Shapiro BA, Warren J, Egol AB, et al: Practice parameters for sustained neuromuscular blockade in the adult critically ill patient: An executive summary. Society of Critical Care Medicine. Crit Care Med 1995; 23:1601-1605
2. Murray MJ, Cowen J, DeBlock H, et al; Task Force of the American College of Critical Care Medicine (ACCM) of the Society of Critical Care Medicine (SCCM), American Society of Health-System Pharmacists, American College of Chest Physicians: Clinical practice guidelines for sustained neuromuscular blockade in the adult critically ill patient. Crit Care Med 2002; 30:142-156
3. Slutsky AS: Neuromuscular blocking agents in ARDS. N Engl J Med 2010; 363:1176-1180
4. Warr J, Thiboutot Z, Rose L, et al: Current therapeutic uses, pharmacology, and clinical considerations of neuromuscular blocking agents for critically ill adults. Ann Pharmacother 2011; 45:1116-1126
5. Salciccioli JD, Cocchi MN, Rittenberger JC, et al: Continuous neuromuscular blockade is associated with decreased mortality in postcardiac arrest patients. Resuscitation 2013; 84:1728-1733
6. Mehta S, Burry L, Fischer S, et al; Canadian Critical Care Trials Group: Canadian survey of the use of sedatives, analgesics, and neuromuscular blocking agents in critically ill patients. Crit Care Med 2006; 34:374-380
7. Cochrane Collaboration: Cochrane: Review Manager. Edition 5.2. Edited by Centre TNC. Copenhagen, Denmark, Cochrane Collaboration, 2012
8. Kavanagh BP: The GRADE system for rating clinical guidelines. PLoS Med 2009; 6:e1000094
9. Guyatt GH, Oxman AD, Kunz R, et al: GRADE guidelines: 2 Framing the question and deciding on important outcomes. J Clin Epidemiol 2011; 64:395-400
10. Burke RE: Motor unit properties and selective involvement in movement. Exerc Sport Sci Rev 1975; 3:31-81
11. Salpeter MM, Loring RH: Nicotinic acetylcholine receptors in vertebrate muscle: Properties, distribution and neural control. Prog Neurobiol 1985; 25:297-325
12. Colquhoun D, Sakmann B: Fast events in single-channel currents activated by acetylcholine and its analogues at the frog muscle endplate. J Physiol 1985; 369:501-557
13. Ebashi S, Endo M: Calcium ion and muscle contraction. Prog Biophys Mol Biol 1968; 18:123-183
14. Colman H, Nabekura J, Lichtman JW: Alterations in synaptic strength preceding axon withdrawal. Science 1997; 275:356-361
15. Fonnum F: Radiochemical micro assays for the determination of choline acetyltransferase and acetylcholinesterase activities. Biochem J 1969; 115:465-472
16. Volknandt W, Zimmermann H: Acetylcholine, ATP, and proteoglycan are common to synaptic vesicles isolated from the electric organs of electric eel and electric catfish as well as from rat diaphragm. J Neurochem 1986; 47:1449-1462
17. Naguib M, Flood P, McArdle JJ, et al: Advances in neurobiology of the neuromuscular junction: Implications for the anesthesiologist. Anesthesiology 2002; 96:202-231
18. Bajgar J: Organophosphates/nerve agent poisoning: Mechanism of action, diagnosis, prophylaxis, and treatment. Adv Clin Chem 2004; 38:151-216
19. Lindstrom J: Nicotinic acetylcholine receptors in health and disease. Mol Neurobiol 1997; 15:193-222
20. Thesleft S: The mode of neuromuscular block caused by acetylcholine, nicotine, decamethonium and succinylcholine. Acta Physiol Scand 1955; 34:218-231
21. Paton WD: Mode of action of neuromuscular blocking agents. Br J Anaesth 1956; 28:470-480
22. Watling SM, Dasta JF: Prolonged paralysis in intensive care unit patients after the use of neuromuscular blocking agents: A review of the literature. Crit Care Med 1994; 22:884-893
23. Minsaas B, Stovner J: Artery-to-muscle onset time for neuromuscular blocking drugs. Br J Anaesth 1980; 52:403-407
24. Pino RM, Hassan H: Monitoring of neuromuscular blockade. Curr Opin Anaesthesiol 1995; 8:348-350
25. Fuchs-Buder T, Claudius C, Skovgaard LT, et al; 8th International Neuromuscular Meeting: Good clinical research practice in pharmacodynamic studies of neuromuscular blocking agents II: The Stockholm revision. Acta Anaesthesiol Scand 2007; 51:789-808
26. McManus MC: Neuromuscular blockers in surgery and intensive care, Part 1. Am J Health Syst Pharm 2001; 58:2287-2299
27. Vizi ES, Lendvai B: Side effects of nondepolarizing muscle relaxants: Relationship to their antinicotinic and antimuscarinic actions. Pharmacol Ther 1997; 73:75-89
28. Hibbs RE, Zambon AC: Agents acting at the neuromuscular junction and autonomic ganglia. In: Goodman & Gilman's The Pharmacological Basis of Therapeutics. Twelfth Edition. Brunton LL, Chabner BA, Knollmann BC (Eds). New York, McGraw-Hill, 2011
29. Hou VY, Hirshman CA, Emala CW: Neuromuscular relaxants as antagonists for M2 and M3 muscarinic receptors. Anesthesiology 1999, 88:744-750
30. Lee C: Conformation, action, and mechanism of action of neuromuscular blocking muscle relaxants. Pharmacol Ther 2003; 98:143-169
31. Milchert M, Spassov A, Meissner K, et al: Skeletal muscle relaxants inhibit rat tracheal smooth muscle tone in vitro. J Physiol Pharmacol 2009; 60 Suppl 8:5-11
32. Bevan DR, Donati F: Muscle relaxants. In: Clinical Anesthesia. Second Edition. Barash PG, Cullen BF, Stoelting RK (Eds). Philadelphia PA, Lippincott-Raven, 1996, pp 481-508
33. Naguib M, Samarkandi AH, Bakhamees HS, et al: Histamine-release haemodynamic changes produced by rocuronium, vecuronium, mivacurium, atracurium and tubocurarine. Br J Anaesth 1995; 75:588-592
34. Fahey MR, Morris RB, Miller RD, et al: Clinical pharmacology of ORG NC45 (NorcuronTM): A new nondepolarizing muscle relaxant. Anesthesiology 1981; 55:6-11
35. Hilgenberg JC: Comparison of the pharmacology and vecuronium and atracurium with that of other currently available muscle relaxants. Anesth Analg 1983; 62:524-531
36. Spence AG, Barnetson RS: Reaction to vecuronium bromide. Lancet 1985; 1:979-980
37. Futo J, Kupferberg JP, Moss J: Inhibition of histamine N-methyltransferase (HNMT) in vitro by neuromuscular relaxants. Biochem Pharmacol 1990; 39:415-420
38. Levy JH, Davis GK, Duggan J, et al: Determination of the hemodynamics and histamine release of rocuronium (Org 9426) when administered in increased doses under N2O/O2-sufentanil anesthesia. Anesth Analg 1994; 78:318-321
39. Watkins J: Adverse reaction to neuromuscular blockers: Frequency, investigation, and epidemiology. Acta Anaesthesiol Scand Suppl 1994; 102:6-10
40. Basta SJ, Savarese JJ, Ali HH, et al: Histamine-releasing potencies of atracurium, dimethyl tubocurarine and tubocurarine. Br J Anaesth 1983; 55 Suppl 1:105S-106S
41. Scott RP, Savarese JJ, Basta SJ, et al: Atracurium: Clinical strategies for preventing histamine release and attenuating the haemodynamic response. Br J Anaesth 1985; 57:550-553
42. Pancuronium bromide. Bethesda, MD, National Library of Medicine. Available at: http://dailymed.nlm.nih.gov/dailymed/lookup. cfm?setid=d705382b-8aa0-4893-ed9e-bcf7c7d9d0a2. Accessed October 15, 2014
43. Cabal LA, Siassi B, Artal R, et al: Cardiovascular and catecholamine changes after administration of pancuronium in distressed neonates. Pediatrics 1985; 75:284-287
44. Gyermek L, Cantley EM: Comparison of the onset, spontaneous recovery and train of four fade of the clinical neuromuscular block produced by pancuronium and pipecuronium. Int J Clin Pharmacol Ther 1994; 32:600-605
45. Orkin FK, Pegg JR: Cardiac effects of pancuronium bromide. JAMA 1973; 224:630
46. Darwish AK, Challen PD: Unexplained death during anaesthesia. Br J Anaesth 1977; 49:192-193
47. Gordon M: Pharmacology, chemistry and physics for anesthesiology, anesthesia: Implications of co-existing disease. 2013. Med Pharmacol. Available at: http://www.anesthesia2000.com/. Accessed October 15, 2014
48. Sugai Y, Sugai K, Hirata T, et al: The interaction of pancuronium and vecuronium with cardiac muscarinic receptors. Acta Anaesthesiol Scand 1987; 31:224-226
49. Abel M, Book WJ, Eisenkraft JB: Adverse effects of nondepolarising neuromuscular blocking agents. Incidence, prevention and management. Drug Saf 1994; 10:420-438
50. Engbaek J, Ording H, Sørensen B, et al: Cardiac effects of vecuronium and pancuronium during halothane anaesthesia. Br J Anaesth 1983; 55:501-505
51. Futo J, Kupferberg JP, Moss J, et al: Vecuronium inhibits histamine N-methyltransferase. Anesthesiology 1988; 69:92-96
52. Husby P, Gramstad L, Rosland JH, et al: Haemodynamic effects of high-dose vecuronium compared with pancuronium in beta-blocked patients with coronary artery disease during fentanyl-diazepam-nitrous oxide anaesthesia. Acta Anaesthesiol Scand 1996; 40:26-31
53. Inoue K, el-Banayosy A, Stolarski L, et al: Vecuronium induced bradycardia following induction of anaesthesia with etomidate or thiopentone, with or without fentanyl. Br J Anaesth 1988; 60:10-17
54. Lines D, Shipton EA: Severe bradycardia and sinus arrest after administration of vecuronium, fentanyl and halothane. A case report. S Afr Med J 1991; 80:200-201
55. Cisatracurium besylate. National Bethesda, MD, Library of Medicine. Available at: https://dailymed.nlm.nih.gov/dailymed/drugInfo. cfm?setid=2ee0358e-2cce-40d3-9fcf-1b9088815c98. Accessed October 15, 2014
56. Jooste E, Klafter F, Hirshman CA, et al: A mechanism for rapacuronium-induced bronchospasm: M2 muscarinic receptor antagonism. Anesthesiology 2003; 98:906-911
57. Soukup J, Doenicke A, Hoernecke R, et al: Cardiovascular effects after bolus administration of cisatracurium. A comparison with vecuronium. Anaesthesist 1996; 45:1024-1029
58. Bevan DR: Newer neuromuscular blocking agents. Pharmacol Toxicol 1994; 74:3-9
59. Booij L: The use of rocuronium in various clinical situations. Asean J Anaesthesiol 2005; 6(Suppl 5):5-14
60. Pollard BJ: Interactions involving relaxants. In: Applied Neuromuscular Pharmacology. Pollard BJ (Ed). Oxford, UK, Oxford University Press, 1994, pp 202-248
61. Klabunde RE: Electrical activity of the heart. In Cardiology Physiology Concepts. Second Edition. Philadelphia, PA, Lippincott, Williams, & Wilkins, 2011, pp 9-40
62. Boehm S, Kubista H: Fine tuning of sympathetic transmitter release via ionotropic and metabotropic presynaptic receptors. Pharmacol Rev 2002; 54:43-99
63. Longnecker DE, Murphy FL: Muscle relaxants. In: Dripps/Eckenhoff/Vandam: Introduction to Anesthesia. Eighth Edition. Zorab R (Ed). Philadelphia, PA: W. B. Saunders, 1992, 110-124
64. Forel JM, Roch A, Marin V, et al: Neuromuscular blocking agents decrease inflammatory response in patients presenting with acute respiratory distress syndrome. Crit Care Med 2006; 34:2749-2757
65. Gainnier M, Roch A, Forel JM, et al: Effect of neuromuscular blocking agents on gas exchange in patients presenting with acute respiratory distress syndrome. Crit Care Med 2004; 32:113-119
66. Papazian L, Forel JM, Gacouin A, et al; ACURASYS Study Investigators: Neuromuscular blockers in early acute respiratory distress syndrome. N Engl J Med 2010; 363:1107-1116
67. Alhazzani W, Alshahrani M, Jaeschke R, et al: Neuromuscular blocking agents in acute respiratory distress syndrome: A systematic review and meta-analysis of randomized controlled trials. Crit Care 2013; 17:R43
68. Lyu G, Wang X, Jiang W, et al: Clinical study of early use of neuromuscular blocking agents in patients with severe sepsis and acute respiratory distress syndrome. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue 2014; 26:325-329
69. The Acute Respiratory Distress Syndrome Network: Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000; 342(18):1301-1308.
70. Burns KE, Adhikari NK, Slutsky AS, et al: Pressure and volume limited ventilation for the ventilatory management of patients with acute lung injury: A systematic review and meta-analysis. PLoS One 2011; 6:e14623
71. De Jonghe B, Sharshar T, Lefaucheur JP, et al; Groupe de Réflexion et d'Etude des Neuromyopathies en Réanimation: Paresis acquired in the intensive care unit: A prospective multicenter study. JAMA 2002; 288:2859-2867
72. Adnet F, Dhissi G, Borron SW, et al: Complication profiles of adult asthmatics requiring paralysis during mechanical ventilation. Intensive Care Med 2001; 27:1729-1736
73. Kesler SM, Sprenkle MD, David WS, et al: Severe weakness complicating status asthmaticus despite minimal duration of neuromuscular paralysis. Intensive Care Med 2009; 35:157-160
74. Leatherman JW, Fluegel WL, David WS, et al: Muscle weakness in mechanically ventilated patients with severe asthma. Am J Respir Crit Care Med 1996; 153:1686-1690
75. Behbehani NA, Al-Mane F, D'yachkova Y, et al: Myopathy following mechanical ventilation for acute severe asthma: The role of muscle relaxants and corticosteroids. Chest 1999; 115:1627-1631
76. Werba A, Klezl M, Schramm W, et al: The level of neuromuscular block needed to suppress diaphragmatic movement during tracheal suction in patients with raised intracranial pressure: A study with vecuronium and atracurium. Anaesthesia 1993; 48:301-303
77. Kerr ME, Sereika SM, Orndoff P, et al: Effect of neuromuscular blockers and opiates on the cerebrovascular response to endotracheal suctioning in adults with severe head injuries. Am J Crit Care 1998; 7:205-217
78. Prielipp RC, Robinson JC, Wilson JA, et al: Dose response, recovery, and cost of doxacurium as a continuous infusion in neurosurgical intensive care unit patients. Crit Care Med 1997; 25:1236-1241
79. Schramm WM, Jesenko R, Bartunek A, et al: Effects of cisatracurium on cerebral and cardiovascular hemodynamics in patients with severe brain injury. Acta Anaesthesiol Scand 1997; 41:1319-1323
80. Rosa G, Orfei P, Sanfilippo M, et al: The effects of atracurium besylate (Tracrium) on intracranial pressure and cerebral perfusion pressure. Anesth Analg 1986; 65:381-384
81. Schramm WM, Strasser K, Bartunek A, et al: Effects of rocuronium and vecuronium on intracranial pressure, mean arterial pressure and heart rate in neurosurgical patients. Br J Anaesth 1996; 77:607-611
82. Hsiang JK, Chesnut RM, Crisp CB, et al: Early, routine paralysis for intracranial pressure control in severe head injury: Is it necessary? Crit Care Med 1994; 22:1471-1476
83. Juul N, Morris GF, Marshall SB, et al: Neuromuscular blocking agents in neurointensive care. Acta Neurochir Suppl 2000; 76:467-470
84. The Hypothermia After Cardiac Arrest Study Group: Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N Engl J Med 2002, 346(8):549-556
85. Bernard SA, Gray TW, Buist MD, et al: Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. N Engl J Med 2002; 346:557-563
86. Salciccioli J, Donnino M: Reply to letter: Continuous neuromuscular blockade is associated with decreased mortality in post-cardiac arrest patients-problems with the data. Resuscitation 2014; 85:e3
87. Baker WL, Geronila G, Kallur R, et al: Effect of neuromuscular blockers on outcomes in patients receiving therapeutic hypothermia following cardiac arrest. Analg Resusc Curr Res 2013; S1. doi: 10.4172/2324-903X.S1-001
88. Sladen RN, Berend JZ, Fassero JS, et al: Comparison of vecuronium and meperidine on the clinical and metabolic effects of shivering after hypothermic cardiopulmonary bypass. J Cardiothorac Vasc Anesth 1995; 9:147-153
89. Guffin A, Girard D, Kaplan JA: Shivering following cardiac surgery: Hemodynamic changes and reversal. J Cardiothorac Anesth 1987; 1:24-28
90. Cruise C, MacKinnon J, Tough J, et al: Comparison of meperidine and pancuronium for the treatment of shivering after cardiac surgery. Can J Anaesth 1992; 39:563-568
91. Peberdy MA, Callaway CW, Neumar RW, et al; American Heart Association: Part 9: Post-cardiac arrest care: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation 2010; 122:S768-S786
92. Heier T, Caldwell JE: Impact of hypothermia on the response to neuromuscular blocking drugs. Anesthesiology 2006; 104:1070-1080
93. Eriksson LI, Viby-Mogensen J, Lennmarken C: The effect of peripheral hypothermia on a vecuronium-induced neuromuscular block. Acta Anaesthesiol Scand 1991; 35:387-392
94. Mueller SW, Winn R, Macht M, et al: Neuromuscular blockade resistance during therapeutic hypothermia. Ann Pharmacother 2011; 45:e15
95. Clifton GL, Miller ER, Choi SC, et al: Lack of effect of induction of hypothermia after acute brain injury. N Engl J Med 2001; 344:556-563
96. Kupchik NL: Development and implementation of a therapeutic hypothermia protocol. Crit Care Med 2009; 37:S279-S284
97. Polderman KH, Herold I: Therapeutic hypothermia and controlled normothermia in the intensive care unit: Practical considerations, side effects, and cooling methods. Crit Care Med 2009; 37:1101-1120
98. Marshall LF: Intercenter variance. J Neurosurg 2001; 95:733-734
99. Magder S: Clinical usefulness of respiratory variations in arterial pressure. Am J Respir Crit Care Med 2004; 169:151-155
100. Monnet X, Rienzo M, Osman D, et al: Passive leg raising predicts fluid responsiveness in the critically ill. Crit Care Med 2006; 34:1402-1407
101. De Backer D, Heenen S, Piagnerelli M, et al: Pulse pressure variations to predict fluid responsiveness: Influence of tidal volume. Intensive Care Med 2005; 31:517-523
102. Lakhal K, Ehrmann S, Benzekri-Lefèvre D, et al: Respiratory pulse pressure variation fails to predict fluid responsiveness in acute respiratory distress syndrome. Crit Care 2011; 15:R85
103. Hofer CK, Senn A, Weibel L, et al: Assessment of stroke volume variation for prediction of fluid responsiveness using the modified FloTrac and PiCCOplus system. Crit Care 2008; 12:R82
104. Tavernier B, Makhotine O, Lebuffe G, et al: Systolic pressure variation as a guide to fluid therapy in patients with sepsis-induced hypotension. Anesthesiology 1998; 89:1313-1321
105. Huang CC, Fu JY, Hu HC, et al: Prediction of fluid responsiveness in acute respiratory distress syndrome patients ventilated with low tidal volume and high positive end-expiratory pressure. Crit Care Med 2008; 36:2810-2816
106. Barr J, Fraser GL, Puntillo K, et al; American College of Critical Care Medicine: Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit. Crit Care Med 2013; 41:263-306
107. Light KP, Lovell AT, Butt H, et al: Adverse effects of neuromuscular blocking agents based on yellow card reporting in the U.K.: Are there differences between males and females? Pharmacoepidemiol Drug Saf 2006; 15:151-160
108. Perry SW: Psychological reactions to pancuronium bromide. Am J Psychiatry 1985; 142:1390-1391
109. Wagner BK, Zavotsky KE, Sweeney JB, et al: Patient recall of therapeutic paralysis in a surgical critical care unit. Pharmacotherapy 1998; 18:358-363
110. Johnson KL, Cheung RB, Johnson SB, et al: Therapeutic paralysis of critically ill trauma patients: Perceptions of patients and their family members. Am J Crit Care 1999; 8:490-498
111. Ballard N, Robley L, Barrett D, et al: Patients' recollections of therapeutic paralysis in the intensive care unit. Am J Crit Care 2006; 15:86-94; quiz 95
112. Arnot-Smith J, Smith AF: Patient safety incidents involving neuromuscular blockade: Analysis of the UK National Reporting and Learning System data from 2006 to 2008. Anaesthesia 2010, 65:1106-1113
113. Punjasawadwong Y, Boonjeungmonkol N, Phongchiewboon A: Bispectral index for improving anaesthetic delivery and postoperative recovery. Cochrane Database Syst Rev 2007(4):CD003843
114. Avidan MS, Jacobsohn E, Glick D, et al; BAG-RECALL Research Group: Prevention of intraoperative awareness in a high-risk surgical population. N Engl J Med 2011; 365:591-600
115. Arbour R: Impact of bispectral index monitoring on sedation and outcomes in critically ill adults: A case series. Crit Care Nurs Clin North Am 2006; 18:227-41, xi
116. Haenggi M, Ypparila-Wolters H, Bieri C, et al: Entropy and bispectral index for assessment of sedation, analgesia and the effects of unpleasant stimuli in critically ill patients: An observational study. Crit Care 2008; 12:R119
117. Nasraway SA, Wu EC, Kelleher RM et al: How reliable is the Bispectral Index in critically ill patients? A prospective, comparative, single-blinded observer study. Crit Care Med 2002; 30:1483-1487
118. Vivien B, Di Maria S, Ouattara A, et al: Overestimation of Bispectral Index in sedated intensive care unit patients revealed by administration of muscle relaxant. Anesthesiology 2003; 99:9-17
119. Arbour R, Waterhouse J, Seckel MA, et al: Correlation between the Sedation-Agitation Scale and the Bispectral Index in ventilated patients in the intensive care unit. Heart Lung 2009; 38:336-345
120. Messner M, Beese U, Romstöck J, et al: The bispectral index declines during neuromuscular block in fully awake persons. Anesth Analg 2003; 97:488-91, table of contents
121. Aho AJ, Lyytikäinen LP, Yli-Hankala A, et al: Explaining entropy responses after a noxious stimulus, with or without neuromuscular blocking agents, by means of the raw electroencephalographic and electromyographic characteristics. Br J Anaesth 2011; 106:69-76
122. Borjian Boroojeny S: The effect of facial muscle contractions on the cerebral state index in an ICU patient: A case report. Cases J 2008; 1:167
123. Inoue S, Kawaguchi M, Sasaoka N, et al: Effects of neuromuscular block on systemic and cerebral hemodynamics and bispectral index during moderate or deep sedation in critically ill patients. Intensive Care Med 2006; 32:391-397
124. Lu CH, Man KM, Ou-Yang HY, et al: Composite auditory evoked potential index versus bispectral index to estimate the level of sedation in paralyzed critically ill patients: A prospective observational study. Anesth Analg 2008; 107:1290-1294
125. Dasta JF, Kane SL, Gerlach AT, et al: Bispectral Index in the intensive care setting. Crit Care Med 2003; 31:998; author reply 998-998; author reply 999
126. Baumann MH, McAlpin BW, Brown K, et al: A prospective randomized comparison of train-of-four monitoring and clinical assessment during continuous ICU cisatracurium paralysis. Chest 2004; 126:1267-1273
127. Foster JG, Kish SK, Keenan CH: A national survey of critical care nurses' practices related to administration of neuromuscular blocking agents. Am J Crit Care 2001; 10:139-145
128. Foster JG, Kish SK, Keenan CH: National practice with assessment and monitoring of neuromuscular blockade. Crit Care Nurs Q 2002; 25:27-40
129. Lagneau F, Benayoun L, Plaud B, et al: The interpretation of train-offour monitoring in intensive care: What about the muscle site and the current intensity? Intensive Care Med 2001; 27:1058-1063
130. Lagneau F, Plaud B, Feller M, et al: TOF monitoring is required to achieve effective transient neuromuscular blockade in ICU patients. Can J Anaesth 2001; 48:319
131. Hattori H, Saitoh Y, Nakajima H, et al: Visual evaluation of fade in response to facial nerve stimulation at the eyelid. J Clin Anesth 2005; 17:276-280
132. Burtin C, Clerckx B, Robbeets C, et al: Early exercise in critically ill patients enhances short-term functional recovery. Crit Care Med 2009; 37:2499-2505
133. Kress JP: Clinical trials of early mobilization of critically ill patients. Crit Care Med 2009; 37:S442-S447
134. Hodgin KE, Nordon-Craft A, McFann KK, et al: Physical therapy utilization in intensive care units: Results from a national survey. Crit Care Med 2009; 37:561-6; quiz 566
135. Eikermann M, Gerwig M, Hasselmann C, et al: Impaired neuromuscular transmission after recovery of the train-of-four ratio. Acta Anaesthesiol Scand 2007; 51:226-234
136. Kress JP, Hall JB: Cost considerations in sedation, analgesia, and neuromuscular blockade in the intensive care unit. Semin Respir Crit Care Med 2001; 22:199-210
137. Pohlman MC, Schweickert WD, Pohlman AS, et al: Feasibility of physical and occupational therapy beginning from initiation of mechanical ventilation. Crit Care Med 2010; 38:2089-2094
138. Ezra DG, Lewis G, Healy M, et al: Preventing exposure keratopathy in the critically ill: A prospective study comparing eye care regimes. Br J Ophthalmol 2005; 89:1068-1069
139. Lenart SB, Garrity JA: Eye care for patients receiving neuromuscular blocking agents or propofol during mechanical ventilation. Am J Crit Care 2000; 9:188-191
140. Rosenberg JB, Eisen LA: Eye care in the intensive care unit: Narrative review and meta-analysis. Crit Care Med 2008; 36:3151-3155
141. Sivasankar S, Jasper S, Simon S, et al: Eye care in ICU. Indian J Crit Care Med 2006; 10(1):11-14
142. Sorce LR, Hamilton SM, Gauvreau K, et al: Preventing corneal abrasions in critically ill children receiving neuromuscular blockade: A randomized, controlled trial. Pediatr Crit Care Med 2009; 10:171-175
143. Tamion F, Hamelin K, Duflo A, et al: Gastric emptying in mechanically ventilated critically ill patients: Effect of neuromuscular blocking agent. Intensive Care Med 2003; 29:1717-1722
144. Martindale RG, McClave SA, Vanek VW, et al; American College of Critical Care Medicine; A.S.P.E.N. Board of Directors: Guidelines for the provision and assessment of nutrition support therapy in the adult critically ill patient: Society of Critical Care Medicine and American Society for Parenteral and Enteral Nutrition: Executive Summary. Crit Care Med 2009; 37:1757-1761
145. Balon JA: Common factors of spontaneous self-extubation in a critical care setting. Int J Trauma Nurs 2001; 7:93-99
146. Bouza C, Garcia E, Diaz M, et al: Unplanned extubation in orally intubated medical patients in the intensive care unit: A prospective cohort study. Heart Lung 2007; 36:270-276
147. Carrión MI, Ayuso D, Marcos M, et al: Accidental removal of endotracheal and nasogastric tubes and intravascular catheters. Crit Care Med 2000; 28:63-66
148. Chevron V, Ménard JF, Richard JC, et al: Unplanned extubation: Risk factors of development and predictive criteria for reintubation. Crit Care Med 1998; 26:1049-1053
149. Chiang AA, Lee KC, Lee JC, et al: Effectiveness of a continuous quality improvement program aiming to reduce unplanned extubation: A prospective study. Intensive Care Med 1996; 22:1269-1271
150. Coppolo DP, May JJ: Self-extubations. A 12-month experience. Chest 1990; 98:165-169
151. Curry K, Cobb S, Kutash M, et al: Characteristics associated with unplanned extubations in a surgical intensive care unit. Am J Crit Care 2008; 17:45-51; quiz 52
152. da Silva PS, Fonseca MC: Unplanned endotracheal extubations in the intensive care unit: Systematic review, critical appraisal, and evidence-based recommendations. Anesth Analg 2012; 114:1003-1014
153. de Groot RI, Dekkers OM, Herold IH, et al: Risk factors and outcomes after unplanned extubations on the ICU: A case-control study. Crit Care 2011; 15:R19
154. de Lassence A, Alberti C, Azoulay E, et al; OUTCOMEREA Study Group: Impact of unplanned extubation and reintubation after weaning on nosocomial pneumonia risk in the intensive care unit: A prospective multicenter study. Anesthesiology 2002; 97:148-156
155. Huang YT: Factors leading to self-extubation of endotracheal tubes in the intensive care unit. Nurs Crit Care 2009; 14:68-74
156. Moons P, Boriau M, Ferdinande P: Self-extubation risk assessment tool: Predictive validity in a real-life setting. Nurs Crit Care 2008; 13:310-314
157. Richmond AL, Jarog DL, Hanson VM: Unplanned extubation in adult critical care. Quality improvement and education payoff. Crit Care Nurse 2004; 24:32-37
158. Yeh SH, Lee LN, Ho TH, et al: Implications of nursing care in the occurrence and consequences of unplanned extubation in adult intensive care units. Int J Nurs Stud 2004; 41:255-262
159. Krinsley JS, Barone JE: The drive to survive: Unplanned extubation in the ICU. Chest 2005; 128:560-566
160. Betbesé AJ, Pérez M, Bak E, et al: A prospective study of unplanned endotracheal extubation in intensive care unit patients. Crit Care Med 1998; 26:1180-1186
161. Boulain T: Unplanned extubations in the adult intensive care unit: A prospective multicenter study. Association des Réanimateurs du Centre-Ouest. Am J Respir Crit Care Med 1998; 157:1131-1137
162. Whelan J, Simpson SQ, Levy H: Unplanned extubation. Predictors of successful termination of mechanical ventilatory support. Chest 1994; 105:1808-1812
163. Tung A, Tadimeti L, Caruana-Montaldo B, et al: The relationship of sedation to deliberate self-extubation. J Clin Anesth 2001; 13:24-29
164. Chang LC, Liu PF, Huang YL, et al: Risk factors associated with unplanned endotracheal self-extubation of hospitalized intubated patients: A 3-year retrospective case-control study. Appl Nurs Res 2011; 24:188-192
165. Chang LY, Wang KW, Chao YF: Influence of physical restraint on unplanned extubation of adult intensive care patients: A case-control study. Am J Crit Care 2008; 17:408-15; quiz 416
166. Kaplow R, Bookbinder M: A comparison of four endotracheal tube holders. Heart Lung 1994; 23:59-66
167. Carlson J, Mayrose J, Krause R, et al: Extubation force: Tape versus endotracheal tube holders. Ann Emerg Med 2007; 50:686-691
168. Owen R, Castle N, Hann H, et al: Extubation force: A comparison of adhesive tape, non-adhesive tape and a commercial endotracheal tube holder. Resuscitation 2009; 80:1296-1300
169. Levy H, Griego L: A comparative study of oral endotracheal tube securing methods. Chest 1993; 104:1537-1540
170. Tominaga GT, Rudzwick H, Scannell G, et al: Decreasing unplanned extubations in the surgical intensive care unit. Am J Surg 1995; 170:586-589
171. Kupas DF, Kauffman KF, Wang HE: Effect of airway-securing method on prehospital endotracheal tube dislodgment. Prehosp Emerg Care 2010; 14:26-30
172. van den Berghe G, Wouters P, Weekers F, et al: Intensive insulin therapy in critically ill patients. N Engl J Med 2001; 345:1359-1367
173. Van den Berghe G, Wilmer A, Hermans G, et al: Intensive insulin therapy in the medical ICU. N Engl J Med 2006; 354:449-461
174. Van den Berghe G, Schoonheydt K, Becx P, et al: Insulin therapy protects the central and peripheral nervous system of intensive care patients. Neurology 2005; 64:1348-1353
175. Hermans G, Wilmer A, Meersseman W, et al: Impact of intensive insulin therapy on neuromuscular complications and ventilator dependency in the medical intensive care unit. Am J Respir Crit Care Med 2007; 175:480-489
176. Van den Berghe G, Wilmer A, Milants I, et al: Intensive insulin therapy in mixed medical/surgical intensive care units: Benefit versus harm. Diabetes 2006; 55:3151-3159
177. Dellinger RP, Levy MM, Carlet JM, et al; International Surviving Sepsis Campaign Guidelines Committee; American Association of Critical-Care Nurses; American College of Chest Physicians; American College of Emergency Physicians; Canadian Critical Care Society; European Society of Clinical Microbiology and Infectious Diseases; European Society of Intensive Care Medicine; European Respiratory Society; International Sepsis Forum; Japanese Association for Acute Medicine; Japanese Society of Intensive Care Medicine; Society of Critical Care Medicine; Society of Hospital Medicine; Surgical Infection Society; World Federation of Societies of Intensive and Critical Care Medicine: Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008; 36:296-327
178. Jacobi J, Bircher N, Krinsley J, et al: Guidelines for the use of an insulin infusion for the management of hyperglycemia in critically ill patients. Crit Care Med 2012; 40:3251-3276
179. Paterson IG, Hood JR, Russell SH, et al: Mivacurium in the myasthenic patient. Br J Anaesth 1994; 73:494-498
180. Tripathi SS, Hunter JM: Neuromuscular blocking drugs in the critically ill. Contin Educ Anaesth Crit Care Pain 2006; 6:117-123
181. Baraka A: Anesthesia and myasthenia gravis. Middle East J Anaesthesiol 1993; 12:9-35
182. Blichfeldt-Lauridsen L, Hansen BD: Anesthesia and myasthenia gravis. Acta Anaesthesiol Scand 2012; 56:17-22
183. Eisenkraft JB, Book WJ, Papatestas AE: Sensitivity to vecuronium in myasthenia gravis: A dose-response study. Can J Anaesth 1990; 37:301-306
184. Itoh H, Shibata K, Nitta S: Difference in sensitivity to vecuronium between patients with ocular and generalized myasthenia gravis. Br J Anaesth 2001; 87:885-889
185. van Kralingen S, van de Garde EM, Knibbe CA, et al: Comparative evaluation of atracurium dosed on ideal body weight vs. total body weight in morbidly obese patients. Br J Clin Pharmacol 2011; 71:34-40
186. Weinstein JA, Matteo RS, Ornstein E, et al: Pharmacodynamics of vecuronium and atracurium in the obese surgical patient. Anesth Analg 1988; 67:1149-1153
187. Varin F, Ducharme J, Théorêt Y, et al: Influence of extreme obesity on the body disposition and neuromuscular blocking effect of atracurium. Clin Pharmacol Ther 1990; 48:18-25
188. Tsueda K, Warren JE, McCafferty LA, et al: Pancuronium bromide requirement during anesthesia for the morbidly obese. Anesthesiology 1978; 48:438-439
189. Schwartz AE, Matteo RS, Ornstein E, et al: Pharmacokinetics and pharmacodynamics of vecuronium in the obese surgical patient. Anesth Analg 1992; 74:515-518
190. Saliho?lu Z, Demiroluk S, Köse Y, et al: Neuromuscular effects of cisatracurium in morbidly obese patients. Middle East J Anaesthesiol 2008; 19:831-839
191. Pühringer FK, Keller C, Kleinsasser A, et al: Pharmacokinetics of rocuronium bromide in obese female patients. Eur J Anaesthesiol 1999; 16:507-510
192. Leykin Y, Pellis T, Lucca M, et al: The pharmacodynamic effects of rocuronium when dosed according to real body weight or ideal body weight in morbidly obese patients. Anesth Analg 2004; 99:1086-1089, table of contents
193. Leykin Y, Pellis T, Lucca M, et al: The effects of cisatracurium on morbidly obese women. Anesth Analg 2004; 99:1090-1094, table of contents
194. Kirkegaard-Nielsen H, Helbo-Hansen HS, Lindholm P, et al: Anthropometric variables as predictors for duration of action of atracurium-induced neuromuscular block. Anesth Analg 1996; 83:1076-1080
195. Feingold A: Pancuronium requirements of the morbidly obese. Anesthesiology 1979; 50:269-270
196. Janmahasatian S, Duffull SB, Ash S, et al: Quantification of lean bodyweight. Clin Pharmacokinet 2005; 44:1051-1065
197. Bloomfield R, Steel E, MacLennan G, et al: Accuracy of weight and height estimation in an intensive care unit: Implications for clinical practice and research. Crit Care Med 2006; 34:2153-2157
198. Jensen GL, Friedmann JM, Henry DK, et al: Noncompliance with body weight measurement in tertiary care teaching hospitals. JPEN J Parenter Enteral Nutr 2003; 27:89-90
199. Jago RH: Arthrogryposis following treatment of maternal tetanus with muscle relaxants. Arch Dis Child 1970; 45:277-279
200. Karnad DR, Guntupalli KK: Critical illness and pregnancy: Review of a global problem. Crit Care Clin 2004; 20:555-76, vii
201. Cartin-Ceba R, Gajic O, Iyer VN, et al: Fetal outcomes of critically ill pregnant women admitted to the intensive care unit for nonobstetric causes. Crit Care Med 2008; 36:2746-2751
202. Karnad DR, Lapsia V, Krishnan A, et al: Prognostic factors in obstetric patients admitted to an Indian intensive care unit. Crit Care Med 2004; 32:1294-1299
203. Duncan PG, Pope WD, Cohen MM, et al: Fetal risk of anesthesia and surgery during pregnancy. Anesthesiology 1986; 64:790-794
204. Mazze RI, Källén B: Reproductive outcome after anesthesia and operation during pregnancy: A registry study of 5405 cases. Am J Obstet Gynecol 1989; 161:1178-1185
205. Mazze RI, Källén B: Appendectomy during pregnancy: A Swedish registry study of 778 cases. Obstet Gynecol 1991; 77:835-840
206. Guay J, Grenier Y, Varin F: Clinical pharmacokinetics of neuromuscular relaxants in pregnancy. Clin Pharmacokinet 1998; 34:483
207. Sharp LM, Levy DM: Rapid sequence induction in obstetrics revisited. Curr Opin Anaesthesiol 2009; 22:357-361
208. Hawkins JL, Johnson TD, Kubicek MA, et al: Vecuronium for rapidsequence intubation for cesarean section. Anesth Analg 1990; 71:185-190
209. Shearer ES, Fahy LT, O'Sullivan EP, et al: Transplacental distribution of atracurium, laudanosine and monoquaternary alcohol during elective caesarean section. Br J Anaesth 1991; 66:551-556
210. Abouleish E, Abboud T, Lechevalier T, et al: Rocuronium (Org 9426) for caesarean section. Br J Anaesth 1994; 73:336-341
211. Cherala SR, Eddie DN, Sechzer PH: Placental transfer of succinylcholine causing transient respiratory depression in the newborn. Anaesth Intensive Care 1989; 17:202-204
212. Dailey PA, Fisher DM, Shnider SM, et al: Pharmacokinetics, placental transfer, and neonatal effects of vecuronium and pancuronium administered during cesarean section. Anesthesiology 1984; 60:569-574
213. Duvaldestin P, Demetriou M, Henzel D, et al: The placental transfer of pancuronium and its pharmacokinetics during caesarian section. Acta Anaesthesiol Scand 1978; 22:327-333
214. Fodale V, Santamaria LB: Laudanosine, an atracurium and cisatracurium metabolite. Eur J Anaesthesiol 2002; 19:466-473
215. Khuenl-Brady KS, Koller J, Mair P, et al: Comparison of vecuroniumand atracurium-induced neuromuscular blockade in postpartum and nonpregnant patients. Anesth Analg 1991; 72:110-113
216. Pan PH, Moore C: Comparison of cisatracurium-induced neuromuscular blockade between immediate postpartum and nonpregnant patients. J Clin Anesth 2001; 13:112-117
217. Smith CE, van Miert MM, Parker CJ, et al: A comparison of the infusion pharmacokinetics and pharmacodynamics of cisatracurium, the 1R-cis 1'R-cis isomer of atracurium, with atracurium besylate in healthy patients. Anaesthesia 1997; 52:833-841
218. A definition of irreversible coma. Report of the Ad Hoc Committee of the Harvard Medical School to Examine the Definition of Brain Death. JAMA 1968; 205:337-340
219. Guidelines for the determination of death. Report of the medical consultants on the diagnosis of death to the President's Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research. JAMA 1981; 246:2184-2186.
220. Rosenberg RN: Consciousness, coma, and brain death-2009. JAMA 2009; 301:1172-1174
221. Wijdicks EF, Pfeifer EA: Neuropathology of brain death in the modern transplant era. Neurology 2008; 70:1234-1237
222. Wijdicks EF: The diagnosis of brain death. N Engl J Med 2001; 344:1215-1221
223. Truog RD: Brain death-too flawed to endure, too ingrained to abandon. J Law Med Ethics 2007; 35:273-281
224. Kuhse H: Response to Ronald M Perkin and David B Resnik: The agony of trying to match sanctity of life and patient-centred medical care. J Med Ethics 2002; 28:270-272
225. Riddick CA, Schneiderman LJ: Distinguishing between effect and benefit. J Clin Ethics 1994; 5:41-43
226. Perkin RM, Resnik DB: The agony of agonal respiration: Is the last gasp necessary? J Med Ethics 2002; 28:164-169
227. Perkin RM, Resnik DB: Response to Kuhse. J Med Ethics 2002; 28:273-4; discussion 274
228. Faber-Langendoen K: The clinical management of dying patients receiving mechanical ventilation. A survey of physician practice. Chest 1994; 106:880-888
229. Hawryluck LA, Harvey WR, Lemieux-Charles L, et al: Consensus guidelines on analgesia and sedation in dying intensive care unit patients. BMC Med Ethics 2002; 3:E3
230. Forel JM, Roch A, Papazian L: Paralytics in critical care: Not always the bad guy. Curr Opin Crit Care 2009; 15:59-66